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C.F. Chen2, L.J. Zhang1. 1National Institute of
Communicable Disease Control and Prevention, China CDC,
Beijing 102206, China, 2Shihezi University, Urumqi 832003,
Xinjiang Province, China
Background: Anaplasma phagocytophilum is an obligatory
intracellular bacterium that causes human granulocytic
anaplasmosis (HGA), which is an emerging tick-borne disease
of public health concern in many areas of the world, and
the ﬁrst case of nosocomial human-to-human transmission
was reported in China, 2006. The biggest challenge for
prevention and control of Anaplasmosis is the rapid diagnosis
of the disease during the early process of illness. Here we
reported on cloning and expression of msp2 protein of
A. phagocytophilum, which is the foundation of developing
rapid diagnosis reagents and vaccine and studying on
pathogenesis of A. phagocytophilum.
Method: 400bp fragments (133 aa) of msp2 outside
of cell membrane, which included important antigenic
determinants were selected according to the results of
Bioinformatics analysis and ampliﬁed by PCR as DNA
of A. phagocytophilum strain Webster as template. The
expression vector (pET30a(+)-msp2) was constructed by
linking the PCR products of msp2 gene fragment into the
pET30a(+) and then transforming it into E. coli BL(plys).
Result: An expected protein band was observed by
IPTG inducting the constructed expression vector and
identifying by SDS-PAGE electrophoresis. Time-of-Flight
mass spectrometry analysis showed that the amino acid
sequences of the recombinant protein were 100% homology
with that of the goal protein in the study. Western-Blot
analysis demonstrated that the protein positively reacted
with rabbit serum immunized with A. phagocytophilum.
Conclusion: A highly expression and puriﬁed recombinant
msp2 proteins of A. phagocytophilum was obtained and a
similar natural immunogenicity of A. phagocytophilum was
noticed.
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PP-248 Pleural effusion in dengue: a cross-sectional
study from Karachi
K. Ejaz1,2 *, M. Khursheed2, A. Raza2. 1Dow University of
Health Sciences, 2Aga Khan University Hospital, Pakistan
Background: To study the presentation pattern of Pleural
Effusion (PEf) among dengue patients in Karachi. Also to
explore limitations faced by the physicians of a developing
country in identifying it.
Methods: A cross-sectional study was conducted on
patients being admitted at Aga Khan University Hospital
in between January 2005 to September 2008. Information
on presentation patterns and radiological investigation used
to conﬁrm PEf were noted. Data was entered and analyzed
in SPSSv16 using Chi Square Test.
Results: Out of total 663 patients, 50 (71%) had PEf
as diagnosed by radiographic modalities. Among them
were 31 (62%) males and 19 (38%) females. Mean age of
presentation was 32±15 years. Majority 23 (46%) had right-
sided PEf. Only 309 patients showed respiratory clinical signs
and symptoms, 299 (97%) had their Chest X-ray and 10 (3%)
had Ultrasound Abdomen studied. Severity of Dengue to PEf
and clinical features are shown in Table I and II respectively.
Among the radiological conﬁrmed dengue patients with
PEf, 44 (90%) showed altered haem-concentration with
an insigniﬁcant odd ratio of 0.7 (p value = 0.56, 95%CI:
0.263 2.066).
Conclusion: In comparison to others less number of our
patients had PEf. Diagnostic modality preferred by our
physicians was Chest X-ray.
Table 1. Comparison of severity of denge to pleural effusion
Variable Dengue severity frequency (%)
DF DHF DSS
Presence of effusion (n = 45) 43 (96%) 1 (2%) 1 (2%)
Severity of effusion (n = 37)
Mild 35 (97%) 1 (3%)
Moderate 1 (100%)
Side of effusion (n = 43)
Right 22 (96%) 1 (4%)
Left 7 (100%)
Both 12 (92%) 1 (8%)
DF, dengue fever; DHF, dengue hemorrhage fever; DSS, dengue shock
syndrome.
Parameter (units) Mean±SD
Temperature (\erdeg;C) 38±9
Systolic BP (mmHg) 113±19
Diastolic BP (mmHg) 73±14
Pulse pressure (beats/min) 39±16
Hct (gm/dl) 42±9
Plt (×109/L) 37±31
PT (s) (n = 243) 13±3
APTT (s) (n = 241) 44±15
mmHg: millimeters of mercury; Hct: hematocrit; Plt: Platelets;
PT: prothrombin time; APTT: activated partial thromboplastin time.
PP-249 Characteristics of febrile thrombocytopenia
during dengue epidemic 2010 in Rawalpindi,
Pakistan
S. Umar1, O. Ashraf1 *, M. Umar2. 1Shifa College of
Medicine, 2Holy Family Hospital, Pakistan
Background: This study aims to determine clinical and
laboratory proﬁle along with disease outcome of all
cases admitted in Holy Family Hospital with febrile
thrombocytopenia during an outbreak of dengue fever in
Rawalpindi, Pakistan. We also wish to highlight the need of
an effective prevention-control program.
Method: This cross-sectional study included 500 patients
admitted in the isolation ward of Holy family Hospital, a
public tertiary care hospital, presenting with acute febrile
illness during dengue outbreak 2010. Only patients who
full ﬁlled the WHO criteria for acute dengue (fever and +2
of the following symptoms: headache, eye pain, myalgia,
arthralgia, leukopenia, rash, and bleeding) were included.
Results: A total of 500 patients were admitted with
suspected diagnosis of dengue fever, of which 34 (6.8%)
cases were conﬁrmed with IgM serology. 452 (90.4%) were
clinically classiﬁed as DF, 47 (9.4%) as DHF and 1 (0.2%)
as DSS. 359 (72%) of the cases were from the age
group 15 44 years, with 335 (67%) males and 165 (33%)
females. Maximum number of patients 294 (62%) were
seen in October. The most prevalent symptoms were fever
500 (100%), Bleeding 290 (58%) Body Aches 237 (47.5%),
Nausea 210 (42%) and Headache 103 (20.6%). Most
common bleeding presentation was gum bleed 76 (25.6%).
Main hematological abnormalities were thrombocytopenia
